| 12509451 |
Heteroaryl amide inhibitors of CD38 |
Jonathan Allen Coe, Eric Verdin, Roberto Perrone, Margaret Jackson, Frederick Nelson +2 more |
2025-12-30 |
|
| 12427157 |
Methods for treatment of diseases involving acidic or hypoxic diseased tissues |
Daniel Richard Marshall, Johanna Marie Csengery, Dalton King, Yana K. Reshetnyak, Oleg A. Andreev +1 more |
2025-09-30 |
|
| 12410262 |
Peptide conjugates of cytotoxins as therapeutics |
Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire |
2025-09-09 |
|
| 12358929 |
NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu |
2025-07-15 |
|
| 12234212 |
Peptide conjugates of microtubule-targeting agents as therapeutics |
Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire |
2025-02-25 |
|
| 12161624 |
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B |
David R. Anderson, Frank S. Menniti |
2024-12-10 |
$20,259,000 |
| 12162890 |
Heteroaromatic NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2024-12-10 |
$20,259,000 |
| 12145909 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B |
David R. Anderson, Frank S. Menniti |
2024-11-19 |
$43,540,000 |
| 11866444 |
Oxabicycloheptane prodrugs |
John S. Kovach, Anthony Marfat |
2024-01-09 |
$203,000 |
| 11807650 |
NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu |
2023-11-07 |
$64,859,000 |
| 11648253 |
Thienopyrimidinone NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2023-05-16 |
$138,083,000 |
| 11634508 |
Peptide conjugates of cytotoxins as therapeutics |
Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire |
2023-04-25 |
|
| 11555019 |
Peptide conjugates of microtubule-targeting agents as therapeutics |
Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire |
2023-01-17 |
|
| 11541057 |
Thienopyrimidinone NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2023-01-03 |
|
| 11542264 |
Heteroaromatic NMDA receptor modulators and uses thereof |
David R. Anderson, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser |
2023-01-03 |
|
| 11274107 |
NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu |
2022-03-15 |
|
| 11236104 |
Heteroaromatic NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2022-02-01 |
|
| 11236102 |
Oxabicycloheptane prodrugs |
John S. Kovach, Anthony Marfat |
2022-02-01 |
$717,000 |
| 11116749 |
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B |
David R. Anderson, Frank S. Menniti |
2021-09-14 |
|
| 10973825 |
Thienopyrimidinone NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2021-04-13 |
|
| 10933069 |
Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues |
Daniel Richard Marshall, Johanna Marie Csengery, Dalton King, Yana K. Reshetnyak, Oleg A. Andreev +1 more |
2021-03-02 |
|
| 10781174 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B |
David R. Anderson, Frank S. Menniti |
2020-09-22 |
|
| 10752633 |
Heteroaromatic NMDA receptor modulators and uses thereof |
David R. Anderson, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser |
2020-08-25 |
|
| 10626122 |
Heteroaromatic NMDA receptor modulators and uses thereof |
David R. Anderson, Frank S. Menniti, Christopher Fanger |
2020-04-21 |
|
| 10618908 |
Oxabicycloheptane prodrugs |
John S. Kovach, Anthony Marfat |
2020-04-14 |
|
